Jeil Pharma Holdings Inc (002620.KS)
KRW 7990.0
(-3.5%)
KRW 7990.0
(-3.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 794.71 Billion | 792.96 Billion | 762.56 Billion | 761.99 Billion | 731.14 Billion | 142.73 Billion |
| Cost of Revenue | 592.89 Billion | 612.48 Billion | 582.06 Billion | 570.75 Billion | 549.16 Billion | 86.27 Billion |
| Gross Profit | 201.82 Billion | 180.48 Billion | 180.5 Billion | 191.23 Billion | 181.97 Billion | 56.45 Billion |
| Operating Expenses | 193.66 Billion | 188.03 Billion | 189.48 Billion | 168.75 Billion | 172.97 Billion | 45.5 Billion |
| Selling, General and Administrative Expenses | 147.62 Billion | 79.43 Billion | 86.32 Billion | 80.19 Billion | 90.16 Billion | 24.38 Billion |
| Research and Development Expenses | 46.03 Billion | 41.56 Billion | 39.67 Billion | 24.73 Billion | 22.45 Billion | 4.51 Billion |
| Other Expenses | - | 67.03 Billion | 63.48 Billion | 63.83 Billion | 60.35 Billion | 1.18 Billion |
| Cost and Expenses | 783.12 Billion | 800.51 Billion | 771.54 Billion | 739.51 Billion | 722.13 Billion | 131.78 Billion |
| Operating Income | 20.92 Billion | -7.54 Billion | 1.55 Billion | 34.68 Billion | 17.73 Billion | 10.94 Billion |
| Interest Expense | 10.67 Billion | 5.95 Billion | 3.28 Billion | 3.19 Billion | 2.85 Billion | 1.01 Billion |
| Income Tax Expense | -740.81 Million | -715.62 Million | 6.74 Billion | 15.88 Billion | 13.25 Billion | 2.48 Billion |
| Earnings before Tax | -13.98 Billion | -83.86 Billion | -6.12 Billion | 30.82 Billion | -82.59 Billion | 9.78 Billion |
| Net Income | -16.24 Billion | -83.14 Billion | -12.87 Billion | 11.43 Billion | -95.85 Billion | 7.06 Billion |
| Earnings Per Share Basic | -1059.00 | -5416.22 | -838.38 | 744.64 | -6244.10 | 1362.57 |
| Earnings Per Share Diluted | -1058.54 | -5416.22 | -838.38 | 744.64 | -6244.10 | 1362.57 |
| Weighted Average Shares Outstanding | 15.34 Million | 15.35 Million | 15.35 Million | 15.35 Million | 15.35 Million | 5.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.35 Million | 15.35 Million | 15.35 Million | 15.35 Million | 15.35 Million | 5.18 Million |
| Gross Margin | 0.25 | 0.23 | 0.24 | 0.25 | 0.25 | 0.40 |
| EBIT Margin | 0.04 | -0.09 | 0.01 | 0.06 | 0.03 | 0.09 |
| Profit Margin | -0.02 | -0.10 | -0.02 | 0.02 | -0.13 | 0.05 |
| EBITDA | 33.47 Billion | -72.71 Billion | 6.14 Billion | 43.33 Billion | -78.88 Billion | 12.6 Billion |
| Earnings Before Tax Margin | 0.03 | -0.01 | 0.00 | 0.05 | 0.02 | 0.08 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 195 Billion | 186.61 Billion | 794.71 Billion | 200.43 Billion | 194.76 Billion | 199.34 Billion |
| Cost of Revenue | 143.55 Billion | 139.8 Billion | 592.89 Billion | 148.49 Billion | 147.73 Billion | 148.9 Billion |
| Gross Profit | 51.45 Billion | 46.81 Billion | 201.82 Billion | 51.94 Billion | 47.03 Billion | 50.43 Billion |
| Operating Expenses | 65.83 Billion | 48.75 Billion | 190.23 Billion | 53.31 Billion | 46.54 Billion | 49.58 Billion |
| Selling, General and Administrative Expenses | 37 Billion | 38.1 Billion | - | 38.56 Billion | 19.76 Billion | 19.93 Billion |
| Research and Development Expenses | 8.89 Billion | 10.64 Billion | - | 14.74 Billion | 10.68 Billion | 12.76 Billion |
| Other Expenses | -19.93 Billion | 92.41 Million | 4.2 Billion | 4.62 Billion | -646.67 Million | 169.62 Million |
| Cost and Expenses | 209.39 Billion | 188.55 Billion | 783.12 Billion | 201.8 Billion | 194.28 Billion | 198.48 Billion |
| Operating Income | -14.38 Billion | -1.93 Billion | 11.59 Billion | -1.36 Billion | 485.55 Million | 857.76 Million |
| Interest Expense | 2.27 Billion | 2.7 Billion | 10.67 Billion | 2.57 Billion | 2.77 Billion | 2.77 Billion |
| Income Tax Expense | 5.62 Billion | 687.82 Million | -740.81 Million | -2.49 Billion | 414.65 Million | 985.89 Million |
| Earnings before Tax | -22.98 Billion | -3.28 Billion | -23.31 Billion | -33.64 Billion | -2.42 Billion | 1.16 Billion |
| Net Income | -12.26 Billion | 44.42 Million | -16.24 Billion | -27.05 Billion | -260.14 Million | 1.25 Billion |
| Earnings Per Share Basic | -798.67 | 2.89 | - | -1762.67 | -16.95 | 81.97 |
| Earnings Per Share Diluted | -798.67 | 2.89 | - | -1762.67 | -16.95 | 81.97 |
| Weighted Average Shares Outstanding | 15.35 Million | 15.35 Million | 15.35 Million | 15.35 Million | 15.35 Million | 15.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.35 Million | 15.35 Million | 15.35 Million | 15.35 Million | 15.35 Million | 15.35 Million |
| Gross Margin | 0.26 | 0.25 | 0.25 | 0.26 | 0.24 | 0.25 |
| EBIT Margin | -0.06 | 0.01 | - | 0.01 | 0.02 | 0.02 |
| Profit Margin | -0.06 | 0.00 | -0.02 | -0.13 | -0.00 | 0.01 |
| EBITDA | -10.78 Billion | 1.44 Billion | - | 1.9 Billion | 3.49 Billion | 4.83 Billion |
| Earnings Before Tax Margin | -0.07 | -0.01 | 0.01 | -0.01 | 0.00 | 0.00 |
AMLLF
RISHABH
EICCF
JLHL
1033
002926